| Gene symbol | CD37 | Synonyms | GP52-40, TSPAN26 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.33 | dbXrefs | |
| Description | CD37 molecule | ||||
| GTO ID | GTC0504 |
| Trial ID | NCT04136275 |
| Disease | T-Cell Lymphoma | Non-Hodgkin's Lymphoma | Lymphoma | B-Cell Lymphoma | Leukemia | Hematologic Cancer |
| Altered gene | CD37 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CAR-37 T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | CAR-37 T Cells In Hematologic Malignancies |
| Year | 2020 |
| Country | United States |
| Company sponsor | Massachusetts General Hospital |
| Other ID(s) | 19-087 |
| Vector information | |||||||
|
|||||||
| Cohort 1 | |||||||||||||||||
|
|||||||||||||||||